Article Details
Retrieved on: 2024-12-28 09:44:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vor Biopharma Reports Promising Phase 1/2 Study Results · Vor Bio price target lowered to $8 from $10 at Oppenheimer · Vor Bio price target lowered to ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here